Background: Ageing is the inevitable time-dependent decline in physiological organ function that eventually leads to death. Age is a major risk factor for many of the most common medical conditions, such as cardiovascular disease, cancer, diabetes and Alzheimer's disease. This study reviews currently known hallmarks of ageing and their clinical implications.
Introduction
Ageing is the inevitable time-dependent decline in physiological organ function that eventually leads to death. Age is a major risk factor for the most common diseases such as heart disease, cancer, diabetes and Alzheimer's disease 1 . As the average age expectancy continues to increase (Fig. 1a) 2 , the consequences and issues of age and physiological decline are a common challenge in hospital wards around the world. At the same time, there appears to be a limit, whereby about 100 years seems to be the upper border of human age (Fig. 1a) .
Humans have long sought ways to prolong life ( Fig. 1b ) and restore health, as depicted in the myths of the 'fountain of youth' through various cultures and times in history. The metaphor has served as an illustration for anything that potentially increases longevity. The current search for longevity concerns molecular signals or pathways that may give clues about how age can be manipulated 3 -5 . Indeed, between the black and white events of birth and inevitable death is the grey line of ageing 6 , independent of social class, position or wealth (Fig. 1a,b) . Thus, the search for natural sources of youth (be it testosterone 7 , oestrogen 8 or dopamine 9 ) and other mechanisms has created not only a huge academic interest, but also a commercial industry, including in the surgical fields 9, 10 . In modern society advanced healthcare can keep people alive longer, so the consequences of age and physiological decline become even more important to understand 11, 12 . Surgery is no exception; as surgical capability progresses, the physiological limitations of humans become more prominent. Thus, understanding how ageing works, how 
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Over past decades, research has gained crucial insight into the processes and underlying molecular mechanisms of ageing. Of interest are the shared pathways and mechanisms that may give clues to better understanding and treatment of other diseases, such as cancer. The aim here is to review some of the currently explored molecular hallmarks behind the biology of ageing.
Methods
A literature search of PubMed/MEDLINE using search terms 'age' OR 'ageing' AND 'hallmarks', 'mechanism', 'molecular pathway', 'physiology', 'mitochondria', alone or in combination, was done up to 15 September 2015. Papers from the last decade were prioritized, and comprehensive reviews on topics not otherwise covered in detail in the manuscript were simply cited. Experimental studies and animal models (mice, yeast, nematodes) were included when focusing on important mechanisms of ageing.
Ageing as a universal process
The overall common denominator of ageing is an accumulation of damage to genetic material 13 . This has been shown across species, from yeast to mice and humans 14 . It also seems that interventions affecting many of these processes extend lifespan across species 14, 15 . Some mechanisms have been easier to demonstrate in nematodes and mice, which have a considerably shorter lifespan than humans. Despite differences in lifespan, ageing is a universally inevitable process, which suggests the possible existence of a similarly universal mechanism of regulation. The hallmarks of ageing described in a seminal paper 16 outlined nine biological mechanisms of the ageing process (Fig. 2) . Similar concepts have been grouped into seven pillars of age-related research 17 , many of which have connected and overlapping fields. For the sake of simplicity, the present review focuses on the suggested nine hallmarks and provides a brief overview of each. Notably, the nine hallmarks can be grouped into three main categories (Fig. 3) : the primary hallmarks that cause damage to cellular functions; antagonistic hallmarks in the response to such damage; and, finally, integrative hallmarks that are the result of clinical phenotype, which ultimately contribute to the clinical effects of ageing as seen in physiological loss of reserve, organ decline and reduced function (Fig. 4) . Notably, several of the proposed hallmarks are typical of other related disease processes, including cancer development 18 . As such, reported hallmarks 19 are not fixed functions but evolve as the understanding of disease expands, such as reported for cancer 18 . Thus, the hallmarks of ageing should be viewed as a basic set of mechanisms to understand the processes of ageing.
Damage-inducing mechanisms of ageing
The human body suffers wear and tear from accumulated external exposure (such as radiation exposure, diet), and intrinsic challenges (for example DNA replication errors) to the cellular and molecular checks-and-balance systems. The decline in organ function and the development of disease is an end-effect of accumulated processes that inflict damage at the molecular level. The damage-inducing hallmarks are genomic instability, telomere attrition, epigenetic changes and loss of proteostasis.
Genomic instability
Human DNA is exposed constantly to all kinds of possible mutagens. These can be exogenous such as radiation and chemicals, or endogenous such as free radicals, the by-products of energy production from the electron transport chain. Powerful cellular DNA repair machinery can fix the majority of the damage 20 ; however, some will inevitably escape repair, so mutations and damage accumulate with time 13 . Thus, the older the cell, the higher the likelihood of accumulated genetic instability. This may range from small point mutations to large chromosome breaks and translocations; the implications can be anything from a silent mutation that codes for the same amino acid, to the activation of oncogenes or silencing of tumour suppressor genes.
Accumulated DNA damage is implicated directly in carcinogenesis 21 and other age-associated disorders, such as neurodegenerative diseases. Hereditary non-polyposis colorectal cancer (HNPCC) is caused by a defect in mismatch repair of DNA that leads to microsatellite instability, and a high risk of colorectal and other types of cancer 22 , particularly at a younger age than sporadic colorectal cancer. In sporadic cancers, a defect mechanism similar to that in HNPCC occurs through epigenetic silencing of mismatch repair enzymes, which leads to microsatellite instability. Notably, epigenetic changes and microsatellite instability occur more frequently with older age 23 . Various forms of genomic instability are found across several cancer types and are also associated with age 24, 25 . Thus, finding means to increase DNA stability could potentially reduce the incidence of cancer, cardiovascular diseases and Alzheimer's disease. One suggested way is through dietary restriction 26, 27 . Eating fruits and vegetables has been associated with increased DNA repair and less DNA damage 28 .
Telomere attrition
Telomeres are repetitive nucleotide sequences that protect the ends of chromosomes and maintain genomic stability (Fig. 5) . Telomere dysfunction and genomic instability appear to be of critical importance for ageing at a cellular level 29, 30 . Age-related diseases and premature ageing syndromes are frequently associated with telomere shortening. In 1961, Hayflick and Moorhead 31 noted that human diploid cells lines could be cultured for only a limited number of passages. This gave rise the telomerase theory of ageing and the Hayflick limit 32 . The basis for this theory is the observation that most human somatic cells do not express telomerase, an enzyme capable of extending the telomere ends of human DNA. Human DNA polymerase is incapable of replicating the telomere ends of DNA fully. Thus, each cell division leads to progressive shortening of the DNA strands; eventually, in theory, this progresses into the coding parts of the DNA (Fig. 5) . To avoid this, the cells enter replicative senescence after a certain number of divisions and associated telomere shortening, known as the Hayflick limit.
In people aged over 60 years, short telomere length is associated with earlier death from age-related diseases 33 . Telomerase overexpression can inhibit ageing, but at the expense of increased tumorigenesis 34, 35 . A study 36 of long-lived families found that telomere length was shorter with age in men; importantly, it appeared that telomere length was highly heritable. Finally, telomere shortening is associated with a number of age-related diseases such as osteoarthritis, atherosclerosis, coronary heart disease and atrial fibrillation 37 -39 .
Epigenetic alterations
Epigenetic alteration refers to changes in gene expression that are achieved without affecting the DNA sequence at the base-pair level (Fig. 6 ). Originally referring exclusively Epigenetic modifications, and effect on ageing and disease. LINE/SINE, long/short interspersed nucleotide element; miRNA, microRNA; IGF, insulin-like growth factor; mTOR, mammalian target of rapamycin; lncRNA, long non-coding RNA; SIRT, sirtuin to stable changes that were inherited through multiple rounds of cell division, thus explaining tissue differentiation, the term is presently used to include dynamic and reversible modifications. Epigenetic mechanisms involve DNA methylation, chromatin remodelling (caused by post-translational modification of histones and adenosine 5 ′ -triphosphate (ATP)-dependent chromatin remodelling complexes) and non-coding RNA. Common to these mechanisms is the ability to regulate gene expression without mutating the original base sequence of the affected genes.
DNA methylation
DNA methylation has been suggested as the predictor of human age in genome-wide methylation studies 40 -42 . DNA methylation in mammals occurs predominantly at CpG islands, which are associated with about half of all human gene promoters, and regulate gene expression according to the density of added methyl groups by physically hindering/making available DNA sites necessary for transcription. The number of methylated genes may vary with age and exposures, and as such represents a risk measure other than chronological age itself. One study 43 that examined the difference between DNA methylation age and chronological age measured in cohorts of elderly people correlated increased risk of death with methylation status, which was independent of other known risk factors, such as smoking, diabetes, hypertension and chronological age alone. Another study 44 demonstrated that obesity was associated with increased methylation (and accelerated ageing) of the liver, potentially contributing to increased risk of liver disease or cancer. This was not reversed by bariatric surgery. Accelerated ageing (by increased methylation of genes) can be viewed as both acquired and heritable traits that predict mortality independently of health status, lifestyle and other known genetic factors.
Histone modification
Histone modifications are a variety of covalent, reversible chemical reactions (acetylations, mono-, di-and tri-methylations and phosphorylations are the most common) that add or subtract moieties to amino acid residues of the histone protein octamers. These modifications occur mostly on the eight N -terminal histone tails that extend from the histone-DNA adducts (nucleosomes), particularly at lysine and serine residues. According to the nature of the modification, the histone-DNA complex loosens or tightens, and gene regulatory proteins are recruited to the affected stretch of DNA, thus regulating gene expression with recurring patterns throughout the genome.
The first histone-associated mechanism affecting ageing is global depletion 45 . Loss or gain of specific histone-modifier proteins, such as histone deacetylases or histone methyltransferases, destabilizes chromatin and gene expression, in a process similar to genetic instability patterns in cancer.
Non-coding RNA
Non-coding RNAs also play an important role in gene silencing and regulation. MicroRNAs (miRNAs) are the most studied class of short (about 22 nucleotides), single-stranded RNAs, with more than 1800 members identified in humans 46 . They may regulate up to 80 per cent of all expressed genes 47 . Feedback loops have been suggested between miRNA gene regulation and other epigenetic mechanisms, because miRNAs are thought to regulate expression of histone methyltransferases.
miRNAs are involved in regulation of senescence-related genes and pathways 48 . miRNA mediates modulation of insulin/insulin-like growth factor (IGF) 1 signalling and target of rapamycin (TOR) signalling pathways, whose conserved role in ageing is well established 16, 49, 50 . Furthermore, miRNAs are also believed to play an important role in immunosenescence, the decline of the immune system, another hallmark of human ageing 51 . Altered miRNA population and expression levels are found in brain, serum and cerebrospinal fluid of patients with Alzheimer's disease 52 .
Common epigenetic features in ageing and cancer
Epigenetic alterations have been linked to detrimental effects that may cause ageing or accelerate ageing processes. They have therefore been studied extensively in the context of cancer and age-related diseases 43, 53, 54 . Variation in epigenetic patterns in an age-dependent manner is frequently observed. Genome-wide studies in ageing cells and tissues have uncovered stochastic DNA methylation drift (gradual increases or decreases at specific loci) that reflects imperfect maintenance of epigenetic marks 55, 56 . Drift creates epigenetic mosaicism in ageing stem cells that could potentially restrict their plasticity and worsen phenotypes such as stem cell exhaustion, and focal proliferative defects that can lead to cancer. Further, hypomethylation of long/short interspersed nucleotide elements is associated with typical senescence-related organ function degeneration, increased cancer risk and poor survival 53 . Up to 80 per cent of genes whose promoter hypermethylation is associated with cancer (such as oestrogen receptor α) have shown a linear tendency to hypermethylation with increasing age 55 .
Whether epigenetic alterations represent the cause or the consequence of ageing, and how they affect the ageing process and age-related diseases remain elusive.
Loss of proteostasis
Proteostasis is the collection of cellular mechanisms involved in maintaining the homeostasis of the proteome, the building and turnover of human proteins 57 . Among its functions is to avoid misfolding and aggregation of damaged and dysfunctional polypeptides that may compromise the vitality of the cell.
The accumulation and aggregation of misfolded proteins is the principal cause of some of the most common age-associated diseases in humans. These mainly include neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, but also non-neurodegenerative diseases such as cataracts 58, 59 . The hallmark of all these diseases is the consistent occurrence of detergent-insoluble protein inclusions and aggregates 58 .
The proteostasis network consists of chaperone-mediated folding, proteasomal degradation and autophagy. The failure of any of these components can lead to protein aggregation and proteotoxic effects 16 . Studies have demonstrated a progressive deterioration in the cells' ability to maintain homeostasis of the proteome with age, and protein aggregates and inclusions are found in almost all tissues of the aged organism 60 .
Molecular chaperones
Molecular chaperones are small proteins that assist native polypeptide chains in the folding into functional protein structures. The most important of these chaperones are the heat-shock family (HSF) of proteins. The transcription of these chaperones is upregulated by cellular stress (including heat shock, hence their name). In mammalian cells the transcription factor HSF1 is considered the master regulator of the heat-shock response, which is the increased transcription of chaperones in response to increased levels of unfolded proteins 58 . The heat-shock proteins are part of a system of damage-associated molecular proteins (DAMPs), which are closely involved in ageing and cancer risk 61 . However, the roles these proteins may take is complex and may vary between disease states, so a better clinical understanding is needed to use this knowledge in patients 62, 63 .
Proteloytic systems
The proteolytic systems, ubiquitin-proteasome and autophagy-lysosome pathways are also integral parts of proteostasis. Proteasome activation delays ageing in vivo and in vitro in a variety of laboratory organisms and is an evolutionarily conserved mechanism 64 . Proteasome activity was found to be high in centenarians, and it has been postulated to be one of the main mechanisms for their healthy ageing 65 . Furthermore, proteasome activation is also feasible through a wide range of different compounds and genetic manipulations, and might in future provide possible pharmacological methods to aid healthy ageing and longevity 58, 64 . Among the activating compounds are dietary fatty acids, pollen, algae extract, spices and several synthetic compounds. Several of these have resulted in prolonged and healthy living in laboratory animal models and human cell lines 65 .
Autophagy
Autophagy is the lysosome-mediated degradation of cytosolic components: a way for the cells to get rid of misfolded proteins, damaged organelles and intracellular pathogens 66, 67 . Calorie restriction has long been known to be a potent way of life extension, and many of the mechanisms thought to mediate this effect appear to converge on, and mediate, autophagy. Calorie restriction downregulates the target of the rapamycin/S6K pathway and upregulates sirtuin (SIRT) 1 deacetylase and the adenosine 5 ′ -monophosphate (AMP)-dependent protein kinase pathway, all pathways that also upregulate autophagy 66, 68, 69 . Upregulation of autophagy is sufficient to extend lifespan in nematodes, flies and mice, and this life extension effect is abolished by knockdown of different autophagy components 66 . Autophagy gene polymorphism has been linked to colorectal 70 and breast 71 cancer, and to age-related diseases such as osteoarthritis 72 , senile osteoporosis 73 and neurodegenerative disease 74 .
Among the pharmacological compounds identified to increase autophagy is the TOR inhibitor rapamycin, the acetyltransferace inhibitor spermidine, and resveratrol, a compound isolated from the skin of red grapes and popularized as the central compound in the wine theory of the French longevity paradox 75 . Rapamycin (sirolimus) is capable of extending lifespan in several model organisms including mice, but at the cost of metabolic side-effects 76 -78 . Rapamycin has also been shown to improve outcome in animal models of neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's 79 . Resveratrol is an activator of deacetylases such as SIRT1 and has been shown to extend life in mice receiving high-calorie diets 80 . Spermidine extends lifespan in yeast, flies, worms and human cells, and is a promising compound for future pharmacological development 15, 81 . The pathophysiological impact of deregulated autophagy, however, includes neoplasia, cardiovascular diseases, altered immune function, neurodegenerative diseases and ageing.
Antagonistic responses to damage
As a response to molecular and cellular damage mechanisms, the human body induces antagonistic hallmarks which come in the form of deregulated nutrient sensing, mitochondrial dysfunction and induction of cellular senescence. Notably, these antagonistic forms may be beneficial at low intensity, such as senescence protecting the cell from carcinogenic transformation, but may indeed induce the ageing process at high intensity. Thus, each of the processes is central in ageing and also plays a role in disease development.
Deregulated nutrient sensing
Humans are dependent on the ability to use nutrients and fluids for growth and maintenance of bodily functions throughout life. Glucose is the essential substrate, and the human body is programmed always to keep its levels within a narrow range. Homeostatic mechanisms in mammals respond to different hormones and nutrients to maintain blood glucose at physiological levels. In old age, many of these sensors and molecular targets are lost or downregulated, which is why identifying molecular pathways that delay the onset of metabolic decline are under intense investigation. Insulin insensitivity represents part of the metabolic decline, whereby insulin-sensitive tissues show a reduced capacity for effective nutrient uptake and utilization 82 . Common features of human ageing includes an increase in visceral fat mass, loss of lean mass, reduced insulin sensitivity resulting in glucose intolerance, and an increase in muscle ragged red fibres 83 . All of these are linked to diseases associated with old age, such as cardiovascular and metabolic disorders, muscle atrophy, neurodegenerative diseases and susceptibility to cancer.
The ability to use nutrients in metabolic processes is vital at the cellular level, and disruptions in nutrient uptake mechanisms disturb cellular homeostasis. Mitochondria are organelles found within cells, and are key players in the use of substrates for energy production. Consequently, any deterioration in mitochondrial DNA, biogenesis, dynamics or integrity affects the whole body, resulting in the deregulated metabolism associated with human ageing 84 . Associated with growth and insulin regulation are growth-promoting hormones such as growth hormone (anterior pituitary gland) and its secondary mediator IGF-1 (made primarily in the liver), which both decline in old age. Insulin and IGF-1 signalling pathways share the same intracellular downstream targets and are among the most evolutionarily conserved pathways across a wide range of species 49, 50, 85 . Any interference with normal signalling and function will therefore affect metabolic integrity. Consequently, mutations and downregulation of targets in these pathways have been associated with increased longevity 49, 50, 85 . The same downstream targets are among the most commonly mutated in cancer, displaying the opposite of cellular decline: uncontrolled cell division 86 .
Dietary or calorie-restriction models
Dietary or calorie-restriction models are based on low-calorie intake throughout life. They have been associated with longevity in organisms ranging from yeast to nematodes and animals 87 -89 . Calorie-restricted diets are difficult for humans 90 , which led to the investigation of possible pharmacological substitutes that could induce the same beneficial metabolic response 91 . Of interest is the effect of bariatric surgery in the elderly on cognition and cellular longevity 92 -94 . However, bariatric surgery did not reverse the accelerated epigenetic ageing associated with fatty liver 44 .
A growing body of evidence suggests that intermittent fasting may trigger the same biological mechanisms as dietary or calorie restriction. These include improved mitochondrial fitness and an increased autophagy response. These have beneficial biological effects including increased circulation and cardiovascular disease protection, and modulation of reactive oxygen species and inflammatory cytokines, in addition to having antimutagenic, antibacterial and anticarcinogenic effects 95 . Autophagy plays an important role in recycling cellular constituents upon starvation and maintaining cellular energy homeostasis using the lysosomal machinery 96 . It has emerged as a distinct death pathway alongside apoptosis and necroptosis 96 . Autophagy functions initially as a rescue mechanism but, if pronounced, it turns into a death-promoting pathway. The turnover of damaged mitochondria by autophagy, termed mitophagy, is important for cellular health and serves as one of the major responses to mitochondrial dysfunction. Others include the mitochondrial unfolded-protein response, involving the protein-folding machinery of chaperones and proteases in response to an accumulation of misfolded proteins in the mitochondria 97, 98 , triggering the apoptotic machinery 98 . Broadly, autophagy has been found to decline with age, and upregulating this pathway is believed to favour longevity by removing damaged organelles and molecules, which might otherwise accumulate and cause pathologies such as Alzheimer's disease 99 . Moreover, it is an attractive pathway to study in relation to cancer development and drug resistance, as well as a target for cancer treatment 100 .
Metabolic flexibility
The metabolic flexibility theory of ageing predicts that longevity is dependent on metabolic health; the maintenance of the respiratory exchange ratio is used as a measurement tool. The respiratory exchange ratio is obtained by indirect calorimetry; the volume of carbon dioxide produced is compared with the amount of oxygen used over a given time. Values of 0⋅7 relate to fatty acids as the main substrate fuel, 0⋅85 signifies a mixture of fatty acids and carbohydrates, and 1 or above suggests that carbohydrates are the only fuel source (Fig. 7) . Metabolic flexibility is dependent on functional, healthy mitochondria that are able to use carbohydrates, proteins and fatty acids for energy production. Upon disruption of mitochondrial integrity the cell is unable to maintain flexible metabolic homeostasis and respond to metabolic demand 101 .
One of the major components of nutrient sensing and metabolic regulation is the mammalian TOR (mTOR), involved in protein translation regulation and cell growth in response to growth signals, and often found upregulated in cancer 102 .
Another important protein in nutrient sensing is AMP-dependent protein kinase, which has an inhibitory effect on mTOR signalling. Nutrient starvation, calorie restriction and exercise, all of which lead to ATP depletion and increased AMP, can activate AMP-dependent protein kinase 103 . The ability of AMP-dependent protein kinase to promote cell survival under environmental stress has been connected to induction of autophagy in many cancer cells, and this kinase plays a role in the control of stress resistance and lifespan extension in a range of species. A high AMP level is often associated with the accumulation of another nucleotide involved in starvation, nicotinamide adenine dinucleotide (NAD). Sirtuins are deacetylases activated by high NAD levels in the cells 26, 104 , typical of nutrient deprivation or growth inhibitory signalling. The role of sirtuins in longevity is still unclear, but it has been shown that they may regulate the insulin signalling pathway and act as regulators of longevity 105 . There are, therefore, important correlations between nutrient-and energy-limiting processes extending lifespan, whereas an excess of nutrient availability instigates diseases associated with ageing.
Mitochondrial dysfunction
The mitochondrial free radical theory of ageing 106 states that, owing to continuous exposure to reactive oxygen species, mitochondrial DNA is especially susceptible to oxidative damage and ageing. Reactive oxygen species can oxidize and damage proteins, lipids and nucleic acids. Levels of reactive oxygen species are increased in old age and have been associated with a decline in mitochondrial Mitochondrial mass and integrity Fig. 7 Mitochondria, metabolic flexibility, and effect of age and disease. a Improving glucose homeostasis in mice prolongs survival and shifts the initiation of decline in metabolic inflexibility. Both wild-type and genetically modified mice with improved glucose homeostasis experience the onset of metabolic diseases after loss of metabolic flexibility. b This is correlated with a change in mitochondrial composition in both numbers and appearance; larger mitochondria are found in aged tissues. c The respiratory exchange ratio (RER) is improved in genetically modified mice with improved glucose homeostasis, such that they are able to metabolize glucose more efficiently at increasing age (RER 1) than wild-type mice (reproduced from Riera and Dillin 84 , with permission from Nature Publishing Group; © 2015)
integrity as the mitochondria are the main producers of these radicals. There has been a large effort to identify effective antioxidants, or agents that may downregulate the levels of these radicals, and thus prolong life.
One model used to study the effect of reactive oxygen species in ageing is based on the creation of electron transport chain mutants. This work has mainly been done in the nematode Caenorhabditis elegans, where Mit mutants with decreased respiratory activity are associated with longevity 107 . In humans, mutations in some of the same genes that produce longevity in Mit mutants paradoxically result in devastating diseases. This observation remained puzzling until it was discovered that both humans and worms exhibit a threshold response to mitochondrial electron transport chain perturbation 108 . This threshold effect can be mediated, at least in part, by intramitochondrial and intermitochondrial complementation, as all cells contains numerous mitochondria 109 . Although a high level of mitochondrial disruption is obviously undesirable in humans, it is notable that even mammals can achieve a longer life by mitigating low levels of mitohormesis 110 .
Mitohormesis and longevity
The mitochondrial free radical theory of ageing remains debated, as studies 111, 112 have shown that high levels of reactive oxygen species do not aggravate the ageing process, but rather slow it down. The emerging concept is that reactive oxygen species may function as signalling molecules along the lines of AMP and NAD, activating pathways involved in cellular homeostasis, where low levels of reactive oxygen species are tolerable. Above a certain threshold, they result in reduced lifespan or cell death 113 .
Mitohormesis is the response of mitochondria to stressors or toxins, which may either upregulate or downregulate several cellular and nuclear processes. Some of these toxins, such as metformin or 2,4-dinitrophenol, which act by limiting the efficiency of the electron transport chain, actually trigger beneficial compensatory responses and increase the overall fitness of the organism 114 -117 . This effect is thought to be the result of upregulation of protective mechanisms within the cells, such as the antioxidant defence 115 and mitochondrial biomass upregulation in response to low-energy signalling pathways 118 .
The timing of mitochondrial perturbation seems to be essential with regard to the extent to which it affects cellular metabolism. This is exemplified by the fact that many diseases associated with old age are related to mitochondrial dysfunction and deregulation of the mitochondrial biomass, as recently described in a model of cardiomyopathy 119 . Furthermore, many cancers show mild to extensive mitochondrial dysregulation, resulting in a metabolic phenotype, which gives these cells a growth advantage compared with non-cancerous cells 120 . As such, cancer cells show increased growth capacity by means of circumventing the mitochondrial dysfunction, even in previously senescent cells. Thus, understanding cancer metabolism and how changes in it may cause cell arrest, and consequently ageing, in addition to related disease processes, is an important opportunity for future research.
Cellular senescence
Cellular senescence is the irreversible process in which a cell stops dividing and undergoes specific phenotypic alterations, including chromatin and secretome changes 16,121 -125 . Historically, senescence was considered a mechanism to protect the organism against the potential dangers arising when damaged cells with chromosome instability continue to divide, a classical mechanism of carcinogenesis 126, 127 . In recent years, cellular senescence has also been associated with ageing and age-related diseases 121, 128, 129 .
Several pathways have been implicated in the road to senescence, although the research is in its infancy. Among the most evident is the DNA damage response pathway, which can be activated by stresses such as reactive oxygen species, certain DNA lesions, telomere attrition, oncogene activation and tumour suppressor gene inactivation. Many oncogenes and tumour suppressors converge on this pathway 121, 127 . The p16 INK4a tumour suppressor protein seems to be very important in age-associated senescence; its tissue levels correlate with chronological age for most murine and human tissues 16,130 -132 . The INK4a/ARF locus is also the genomic locus linked to the highest number of age-associated diseases in a genome-wide association study 133 . Conditional expression of p16 INK4a in mice also results in many of the physiological hallmarks of ageing 134 . This makes the INK4a/ARF locus the best documented gene associated with ageing and age-related disease 16 . In fact, selective removal of INK4a-expressing senescent cells delays onset, and halts progression, of age-related pathologies in mice 135 .
Senescent cells are usually removed by immune surveillance and phagocytosis, but seem to accumulate with age 136 -138 . This accumulation may be the result of their increased production (as it might be expected, owing to the accumulation of DNA and other cell damage with age), as well as the result of decreased immune clearance, as a consequence of immunosenecence 16, 139 .
Senescent cells are not just passive bystanders, but secrete a variety of proinflammatory cytokines, matrix metalloproteinases, interleukins and growth factors 140 . This secretome has been referred to as a senescence-associated secretory phenotype. It is believed that the accumulation of senescent cells and their associated secretome constitutes one of the mechanisms of ageing and age-related diseases. Increased numbers of senescent cells have been found in aged tissues and tissues from patients with chronic age-related disease 121, 141 .
Culprits leading to phenotypical changes of ageing
Finally, stem cell exhaustion and altered intercellular communication represent the rate-limiting steps in the clinical signs of age and ageing. These changes represent intrinsic alterations (loss of stem cells or stem cell function) as well as a change in the communication of cells and organ systems, including the immune system.
Stem cell exhaustion
Stem cells have an important role in ageing. Haematopoietic stem cell exhaustion leads to anaemia; mesenchymal stem cell decline leads to osteoporosis and fractures; and intestinal epithelial stem cell depletion causes decreased intestinal function 16 . All of these are common features of ageing. Muscle stem cells or satellite cell dysfunction have also been implicated in sarcopenia, the muscle loss associated with ageing. Notably, sarcopenia is an independent predictor of postoperative complication rates, discharge disposition and in-hospital mortality after emergency surgery in the very elderly 142 . Using sarcopenia as an objective tool to identify high-risk patients could be beneficial in developing tailored preventive strategies in the elderly.
Altered intercellular communication
The mechanisms discussed above involve intrinsic alterations that affect various cellular components of the molecular machinery. However, changes also occur at the intercellular level, including endocrine, neuroendocrine, neuronal and inflammatory signalling. This may be seen in neurohormonal changes, such as deregulation of the renin-angiotensin system or the insulin-to-insulin growth factor response. Inflammatory reactions tend to increase with age, whereas immunosurveillance against pathogens and premalignant cells declines, thus giving rise to opportunistic infections and growth of malignant cells. Aged-related changes in the immune system, known as immunosenescence, and increased secretion of cytokines by adipose tissue represent the major causes of chronic inflammation 143, 144 . Chronic low-grade systemic inflammation and immunosenescence are intertwined in the pathogenesis of premature ageing, also defined as inflammageing. They give rise to other age-related diseases such as diabetes, arthritis, metabolic syndrome and cardiovascular disease 143 . Inflammageing is associated with frailty, morbidity and mortality in elderly people 145 .
Implications for surgical patients
The sum of the molecular hallmarks produces the clinical picture of: frailty, sarcopenia, anaemia, poor nutrition and a blunted immune response system. This is typical of the elderly patient with cancer, sepsis or in need of surgical correction of failing body systems. Understanding the molecular biology of ageing has several potential clinical implications that may give rise to new ways of managing surgical disease in the elderly. One would be pharmacological manipulation to halt, or even reverse, some of the ageing processes, which may eventually have a positive effect on organ function, organ recovery or ability to heal after surgery. A further understanding of how ageing affects organ systems and induces dysfunction could lead to methods for reversing or limiting these effects in the perioperative phase. Furthermore, finding biomarkers of disease or age dysfunction may replace or support current use of other investigations, such as cardiac or pulmonary function/reserve testing. Knowing the risks could enable prediction or prevention of adverse events from perioperative surgical stresses. Thus, the crude assessment of currently known risk factors such as sarcopenia 142, 146 , hypoalbuminaemia and frailty 147 may become more sophisticated and tailored in the future. As such, mechanisms that can be manipulated, or hallmarks that can be halted, may be essential for the delivery of safer surgery in the elderly 148 .
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